16
EDUCATIONAL WORKSHOPS 2009 CASE PRESENTATION CASE PRESENTATION THREE THREE “He’s got another one, doctor” A difficult case of recurrent MRSA bacteraemia Author: Nick Brown, Addenbrooke’s Hospital Acknowledgement: Sani Aliyu, Sandwell and West Birmingham Hospitals – now Addenbrooke’s Hospital Details of the original case report have been adapted to emphasise particular points

EDUCATIONAL WORKSHOPS 2009

  • Upload
    shiloh

  • View
    35

  • Download
    0

Embed Size (px)

DESCRIPTION

EDUCATIONAL WORKSHOPS 2009. CASE PRESENTATION THREE. “He’s got another one, doctor” A difficult case of recurrent MRSA bacteraemia Author: Nick Brown, Addenbrooke’s Hospital. Acknowledgement: Sani Aliyu, Sandwell and West Birmingham Hospitals – now Addenbrooke’s Hospital - PowerPoint PPT Presentation

Citation preview

Page 1: EDUCATIONAL WORKSHOPS 2009

EDUCATIONAL WORKSHOPS 2009

CASE PRESENTATION THREECASE PRESENTATION THREE

“He’s got another one, doctor” A difficult case of recurrent MRSA bacteraemia

Author: Nick Brown, Addenbrooke’s Hospital

Acknowledgement:Sani Aliyu, Sandwell and West Birmingham Hospitals – now Addenbrooke’s Hospital

Details of the original case report have been adapted to emphasise particular points

Page 2: EDUCATIONAL WORKSHOPS 2009

Sponsored through an unrestricted educational grant from Novartis Pharmaceutical Ltd to help support the

cost of developing and hosting this educational workshop series

Page 3: EDUCATIONAL WORKSHOPS 2009

Background65 y old male

Past history of hypertension and cerebro-vascular disease

July 2003

Aortic aneurysm and complications

Endovascular aortic aneurysm repair (EVAR)

post-operative bleed requiring laparotomy

paraparesis secondary to spinal cord ischaemia

long term suprapubic catheter

longstanding sacral pressure soresAuthor: Nick Brown, Addenbrooke’s Hospital

Page 4: EDUCATIONAL WORKSHOPS 2009

July 2007Admitted with fever four years after aneurysm repair

Blood cultures MRSA (isolate 1)

X-ray pelvis and transoesophageal echocardiogram (TOE) – normal

2 weeks iv vancomycin plus oral rifampicin, then stopped

Question:

What was the source of infection?

How would you have treated it?

Author: Nick Brown, Addenbrooke’s Hospital

Page 5: EDUCATIONAL WORKSHOPS 2009

July 20075 days later- pyrexia MRSA again in blood cultures (isolate 2)

Re-started vancomycin plus rifampicin for 4 weeks

Home on doxycycline plus rifampicin for a further 4 weeks

Author: Nick Brown, Addenbrooke’s Hospital

Page 6: EDUCATIONAL WORKSHOPS 2009

November 2007re-admitted with fever and back pain after 9 days at homeBlood cultures MRSA (isolate 3) Transthoracic echocardiogram (TTE) – normalMagnetic resonance imaging (MRI) spine - normalWCC scan suggestive of increased uptake in lower vertebra1 week vancomycin, then MIC for MRSA strain reported as 3 mg/Lintravenous linezolid for 10 days, then home on further 4 weeks oral

Author: Nick Brown, Addenbrooke’s Hospital

Page 7: EDUCATIONAL WORKSHOPS 2009

Imaging 1: Indium-111 labelled white cell scan showing localised area of increased uptake in the lower abdomen or perhaps in the vertebrae

Here it is

Page 8: EDUCATIONAL WORKSHOPS 2009

Population analysis of GISA

0

1

2

3

4

5

6

7

8

9

10

0 2 4 6 8 10 12 14 16

Vancomycin (mg/L)

log

10 c

fu/m

L

Mu3

Mu50

Sensitive S aureus

Patient MRSA

Page 9: EDUCATIONAL WORKSHOPS 2009

January 2008re-admitted in septic shock, day 38 linezolid

MRSA in blood (isolate 4)

intravenous daptomycin - five fold rise in CK, therefore stopped (was on a statin at the same time)

blood cultures MRSA (isolate 5)

Quinupristin/dalfopristin plus fusidic acid for 12 weeks

Author: Nick Brown, Addenbrooke’s Hospital

Page 10: EDUCATIONAL WORKSHOPS 2009

Late February 2008Blood cultures sterile by week 3 of quinupristin/dalfopristin plus

fusidic acid

inflammatory markers settling

Computerised axial tomography (CT) scan at week 7 – ‘increased thickness of aneurysm wall compared to previous scans’

Author: Nick Brown, Addenbrooke’s Hospital

Page 11: EDUCATIONAL WORKSHOPS 2009

Imaging 2: Computerised tomography (CT) scan showing aortic graft in situ with thickening of the aortic wall

Page 12: EDUCATIONAL WORKSHOPS 2009

April 2008Cardiothoracic review - no surgical intervention indicated

11 weeks into quinupristin/dalfopristin treatmentseptic again ESBL-producing E. coli in urine and femoral line tipmeropenem for 10 daysquinupristin/dalfopristin discontinued end of 12 weeks

blood cultures just before quinupristin/dalfopristin stopped MRSA (isolate 6)

Author: Nick Brown, Addenbrooke’s Hospital

Page 13: EDUCATIONAL WORKSHOPS 2009

April 2008Quinupristin/dalfopristin re-started (1 week later) plus daptomycin

4mg/kg

CK levels remain normal

2 weeks - Quinupristin/dalfopristin switched to gentamicin and daptomycin dose increased to 10mg/kg

new femoral line

Author: Nick Brown, Addenbrooke’s Hospital

Page 14: EDUCATIONAL WORKSHOPS 2009

Mid-July 2008Gentamicin stopped after 4 weeks

MRSA bacteraemia persists (isolate 7)

8 weeks into daptomycin treatment - progressive rise in MIC

daptomycin MIC 0.125 mg/L initially, but peaked at 12.0 mg/L

Isolates now also resistant to rifampicin and fusidic acid

Positron emission tomography (PET) scan confirms aortic graft infection

Author: Nick Brown, Addenbrooke’s Hospital

Page 15: EDUCATIONAL WORKSHOPS 2009

Imaging 3: Positron emission tomography (PET) scan showing increased tracer activity in relation to the aortic graft

Page 16: EDUCATIONAL WORKSHOPS 2009

End-July 2008Aortic graft replacedCultures of graft are negative, but S. aureus identified by 16s rDNA

PCRGiven iv linezolid, then oral fosfomycin, doxycycline plus

chloamphenicol for 4 weeks

End-August 2008switched to oral doxycycline alone12 sets of blood cultures negative as at 1 Oct 2008

Author: Nick Brown, Addenbrooke’s Hospital